PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.
CYT-108 is under development for treatment of osteoarthritis. The drug candidate is a endogenous recombinant alpha-2 macroglobulin (A2M). It is administered through intraarticular route. Cytonics is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback